Fig 1.
The entry procedure and study protocol.
Retrospective study (A) and prospective study (B) protocols are shown. LC, liver cirrhosis.
Table 1.
The patients’ backgrounds and cox regression analyses in the retrospective study.
Fig 2.
The annual rate of change of the liver function indices and their association with the prognosis.
Table 2.
The receiver operating characteristic analysis in the retrospective study.
Table 3.
The patients’ backgrounds and cluster analysis in the prospective study.
Table 4.
Univariate and multivariate logistic regression analyses in the prospective study.
Fig 3.
The translation of ALBI and CLDQ scores in the prospective study.
In the 16 cases of the cirrhosis progression group, the median ALBI score worsened from −2.08 to −1.78 (P < 0.001), whereas in the 30 cases of the non-progression group, the median ALBI score significantly improved from −2.15 to −2.43 (P < 0.001, A). Similar to the above, the median CLDQ score worsened from 5.3 to 4.9 (P = 0.034) in the cirrhosis progression group, whereas the median CLDQ score improved from 5.1 to 5.6 (P = 0.018, B) in the non-progression group. ALBI, albumin–bilirubin; CLDQ, Chronic Liver Disease Questionnaire. Error bar, standard deviation of each data.